BioTech Medics, Inc. Closes On Sale Of NeuroLase Medical Laser And Announces Dr. Robert Honigsfeld As A New Advisory Board Member

DALLAS, Jan. 25 /PRNewswire-FirstCall/ -- Keith Houser, CEO of BioTech Medics, Inc., (pink sheets symbol: BTMD) announced today that the Company has delivered a new NeuroLase 150 Medical Device to Albuquerque, New Mexico and to Dr. Louis E. Hubbard, D.C. one week ahead of schedule. Mr. Houser said: "We welcome Dr. Hubbard and his medical center as one of our proposed 100-plus affiliated Pain Management & Wellness Centers across the USA offering safe, drug & surgery-free alternative treatment for pain management."

"It is a pleasure working with Dr. Hubbard. He has studied laser therapy for years and has tried other lasers in his practice. But when Dr. Hubbard was personally administered laser therapy with the NeuroLase he immediately felt a significant difference with the NeuroLase over two competitor lasers he had previously used," stated Mr. Houser.

Additionally, Mr. Houser formally announced the appointment of Robert Honigsfeld, DC, as an Advisory Board Member to BioTech Medics. "Dr. Honigsfeld will be valuable to BTMD in providing academic leadership in assisting the Company in preparing Continuing Education ("CE") Courses in Laser Therapy for medical practitioners," said Mr. Houser. Dr. Honigsfeld is President and CEO, Robert B. Honigsfeld, DC, PC, Dallas, Texas. He is also Consultant/Seminar Moderator, Wholeperson Institute, LLC, Marblehead, Mass., and a Member of the Exam Committee, Texas Impairment Rating Skills Assessment Test (TIRSAT).

He was Executive Director, of the Community Outreach and Special Projects Department at Parker College of Chiropractic, Dallas, Texas (2000-02). He also was Dean of the Center for Clinical Sciences, at Parker College of Chiropractic, Dallas, TX (1998-2000). He has been Advisor to Sharpstown Chiropractic Clinic/Sharpstown Healthcare Clinic, Houston, Texas (1998-2000) and Director, Chiropractic Services, Healthcare Review, Inc., San Antonio, TX (1993-1995). He was with Chiropractic Orthopedics, Sharpstown Chiropractic Clinic, Houston, TX (1979-84).

Dr. Honigsfeld is a 1977 graduate of New York Chiropractic College, Greenvale, NY. He is also a post-graduate of Springfield College, Springfield, MS, with a Masters in Education Degree, and Health & Physical Medicine, 1975. He completed undergraduate studies at Hunter College, New York City, NY, with a B.A. in Health & Physical Education, 1969.

Dr. Honigsfeld has also completed additional post-graduate education at Logan College of Chiropractic/American College of Chiropractic Consultants, Chesterfield, MO 1987; Chiropractic Claims Review, Logan College of Chiropractic, 1987; The Peer Review Qualifying Program, Texas Chiropractic Association, 1983; Texas Chiropractic College, Pasadena, TX, Department Postgraduate Studies, Concentration in Orthopedics, 1981-1984; and New York Chiropractic College, X-ray and Spinography Diploma, 1978.

Dr. Honigsfeld was in the New York State Army National Guard from 1970-1976, and received an Honorable Discharge as a Specialist 5 in the Medical Corps Division. He is licensed in both Texas and Florida.

For More Information Contact BioTech Medics at 972-274-5533 or on Internet at: http://www.biotechmedics.com/.

Safe Harbor for Forward-Looking Statements.

This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, the ability of the company to complete the planned bridge financing, market conditions, the general acceptance of the Company's products and technologies, competitive actors, timing, and other risks described in various Company publications.

CONTACT: Keith Houser of BioTech Medics, +1-972-223-2771

Web site: http://www.biotechmedics.com/